Evidence map›Paper›PMID 32784971›Full record

ReviewInternational journal of molecular sciences2020

Genetics and Epigenetics of Atrial Fibrillation.

Estefanía Lozano-Velasco, Diego Franco, Amelia Aranega, Houria Daimi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Cardiac Manifestations ofHealth science reports · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. miRNAs in Heart Development and Disease.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Estefanía Lozano-VelascoDepartment of Experimental Biology, University of Jaen, 23071 Jaen, Spain.ORCID 0000-0002-5615-2754
Diego FrancoDepartment of Experimental Biology, University of Jaen, 23071 Jaen, Spain.ORCID 0000-0002-5669-7164
Amelia AranegaDepartment of Experimental Biology, University of Jaen, 23071 Jaen, Spain.
Houria DaimiBiochemistry and Molecular Biology Laboratory, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.
Universidad de Jaén · ESUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is known to be the most common supraventricular arrhythmia affecting up to 1% of the general population. Its prevalence exponentially increases with age and could reach up to 8% in the elderly population. The management of AF is a complex issue that is addressed by extensive ongoing basic and clinical research. AF centers around different types of disturbances, including ion channel dysfunction, Ca

Indexed as

Epigenesis, GeneticGene Regulatory NetworksAnimalsAtrial FibrillationDNA MethylationGenetic LociGenome-Wide Association StudyHistone CodeHumansIon ChannelsMicroRNAsRNA, Long NoncodingIon ChannelsMicroRNAsRNA, Long Noncodingatrial fibrillationepigeneticsgene regulation

Identifiers

PMID32784971
PMCPMC7460853
OpenAlexW3048173582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.